Free tool
FAERS Monitor: Chloraprep One-Step
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020832 or its brand name (Chloraprep One-Step, Chlorhexidine Gluconate, Isopropyl Alcohol). Reports on generic versions are filed under their own applications.
Reports
297
Serious
272
92% of reports
Hospitalization
79
Death reported
28
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- sinusitis211
- pain206
- lower respiratory tract infection205
- pruritus192
- rash187
- joint swelling186
- peripheral swelling180
- insomnia179
- impaired healing156
- weight increased156
- stomatitis155
- folliculitis154
- hypersensitivity153
- pyrexia153
- fatigue152
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 2 |
| 2010 | 5 |
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 20 |
| 2016 | 7 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 16 |
| 2020 | 21 |
| 2021 | 71 |
| 2022 | 76 |
| 2023 | 29 |
| 2024 | 33 |
| 2025 | 4 |
| 2026 | 3 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,862 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| folliculitisSignal | 154 | 1055.6 | 944.4 | 158,913 |
| impaired healingSignal | 156 | 338.1 | 303.3 | 51,931 |
| lower respiratory tract infectionSignal | 205 | 320.7 | 297.0 | 64,860 |
| stomatitisSignal | 155 | 181.4 | 162.7 | 27,643 |
| sinusitisSignal | 211 | 146.1 | 135.8 | 30,347 |
| joint swellingSignal | 186 | 109.3 | 100.1 | 19,933 |
| peripheral swellingSignal | 180 | 82.8 | 75.6 | 14,561 |
| hypersensitivitySignal | 153 | 58.4 | 52.3 | 8,647 |
| weight increasedSignal | 156 | 49.4 | 44.3 | 7,418 |
| insomniaSignal | 179 | 47.6 | 43.4 | 8,223 |
| pruritusSignal | 192 | 35.4 | 32.5 | 6,499 |
| pyrexiaSignal | 153 | 31.3 | 28.1 | 4,534 |
| rashSignal | 187 | 30.4 | 27.9 | 5,396 |
| painSignal | 206 | 23.8 | 22.0 | 4,601 |
| fatigueSignal | 152 | 13.8 | 12.4 | 1,865 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.